CSIS Issues Commentary: Tracking Global Compulsory Licensing Trends in Biopharmaceuticals
July 23, 2026
July 23, 2026
WASHINGTON, July 23 -- The Center for Strategic and International Studies issued the following commentary on July 22, 2026, by deputy director and fellow Alexander Kersten and program manager and research associate Shruti Sharma, both of the Renewing American Innovation:
* * *
Tracking Global Compulsory Licensing Trends in Biopharmaceuticals
Secure intellectual property (IP) rights provide a stable and predictable framework for actors in the innovation ecos . . .
* * *
Tracking Global Compulsory Licensing Trends in Biopharmaceuticals
Secure intellectual property (IP) rights provide a stable and predictable framework for actors in the innovation ecos . . .
